Primary dysmenorrhea is a common gynecologic disorder. Dysmenorrheic pain normally has an onset of from 2–12 hours before the start of menses and tapers over the next one to two days. Although the exact etiology is unknown, this condition is associated with an increase in prostaglandin F2α.
In the past, nonspecific treatments such as heat and exercise were tried, with poor results. Little relief was offered by antispasmotics or low-dose aspirin.
Currently, effective therapy for primary dysmenorrhea includes oral contraceptives and prostaglandin synthetase inhibitors. Oral contraceptives should be prescribed only for women who desire contraception and who are candidates for this type of therapy. Prostaglandin synthestase inhibitors can be given to women who do not desire oral contraceptives or those who do not respond to hormonal therapy. Secondary dysmenorrhea should be suspected in women who do not respond to either treatment modality.
RosenwaksZ., Seegar-JonesG.Menstrual pain: its origin and pathogenesis. J Reprod Med1980; 25: 207–12.
2.
OslerM.Standard treatment with spasmolytics and hormones. Acta Obstet Gynecol Scand1979; 87(suppl): 69–72.
3.
KleinJ.R., LittI.F., RosenbergA., UdallL.The effect of aspirin on dysmenorrhea in adolescents. J Pediatr1981; 98: 987–90.
4.
Primary dysmenorrhea.Lancet1980; 1: 800–1.
5.
YlikokalaO., KauppilaA., PuolakkaJ.Naproxen suppository in primary dysmenorrhea. Lancet1979; 1: 278–9.
6.
DingfelderJ.R.Primary dysmenorrhea treatment with prostaglandin inhibitors: a review. Am J Obstet Gynecol1981; 140: 874–9.
7.
BarberH.Dysmenorrhea—part II. The Female Patient.1980; 5: 81–7.
8.
DaWoodM.Y.Primary dysmenorrhea—part I: etiology and diagnosis. The Female Patient1979; 5: 80–5.
9.
MackinnonG.L., ParkerW.A.Current concepts—the management of primary dysmenorrhea. Can Pharm J1982; 1150: 3–8.
10.
DandenellL., LalosO., LisciakJ., SandstromB., BaranyS., NilssonB.Clinical experience of naproxen in the treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand1979; 87(suppl): 95–100.
11.
JacobsenJ., Cavalli-BjorkmanK., LundstromV., NilssonB., NorbeckM.Prostaglandin synthetase inhibitors: a survey and personal clinical experience. Acta Obstet Gynecol Scand1979; 87(suppl): 73–9.
12.
StrombergP., ForslingM.L., AkerlundM.Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea. Obstet Gynecol1981; 58: 206–8.
13.
FraserI.S.Dysmenorrhea: effective new approaches to a controversial problem. Med J Aust1980; 22: 248–9.
14.
MorrisonJ.C., JenningS.Primary dysmenorrhea treated with indomethacin. South Med J1979; 72: 425–8.
15.
AndersonA.B.M., FraserI.S., HaynesP.J., TurnbullA.C.Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhea. Lancet1978; 1: 345–8.
16.
TroboughG., GudermanA.M., EricksonR.R.The effect of exogenous intrauterine progesterone on the amount and prostaglandin F2 content of menstrual blood in dysmenorrheic women. J Reprod Med1978; 21: 153–8.
17.
KrishaU.R., NaikS., MandlekarKC., GuptaV.N., KulkarniV.N., ShethU.K.Flurbiprofen in the treatment of primary dysmenorrhea. Br J Clin Pharmacol1980; 9: 605–8.
18.
KapadiaI., ElderM.G.Flufenamic acid in treatment for primary spasmodic dysmenorrhea; a double-blind crossover study. Lancet1978; 1: 348–50.
19.
AndersonK.E., UlmstenU.Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhea. Br J Obstet Gynecol1978; 85: 142–8.
20.
DaWoodM.Y.Primary dysmenorrhea—part II: treatment. The Female Patient1979; 6: 68–72.
21.
ChanW.V., DaWoodM.Y., FuchsF.Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. Am J Obstet Gynecol1979; 135: 102–8.
22.
Drugs for dysmenorrhea.Med Lett Drugs Ther1979; 21: 81–2.
23.
ShapiroS.S., DiemK.The effect of ibuprofen in the treatment of dysmenorrhea. Curr Ther Res Clin Exp1981; 30: 327–34.
24.
AlvinP.E., LittI.F.Current status of the etiology and management of dysmenorrhea in adolescence. Pediatrics1982; 70: 516–25.
25.
HalbertD.R.Noncontraceptive uses of the pill. Clin Obstet Gynecol1981; 24: 987–93.
26.
ChanW.Y., DaWoodM.Y., FuchsF.Prostaglandins in primary dysmenorrhea: comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives. Am J Med1981; 70: 535–41.
27.
KremserE., MitchellG.M.Treatment of primary dysmenorrhea with a combined type of oral contraceptive—a double-blind study. J Am Coll Health Assoc1971; 19: 195–6.
28.
YlikorkalsO., DaWoodM.Y.New concepts in dysmenorrhea. Am J Obstet Gynecol1980; 7: 833–42.
29.
MorrisonJ.C., LingF.W., FormaonE.K.Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea. South Med J1980; 73: 999–1002.
30.
HenzeM.R., ButtramV., SegreE.The treatment of dysmenorrhea with naproxen sodium: a report on two independent double-blind trials. Am J Obstet Gynecol1977; 127: 818–23.
31.
CashH.C., HampstonP., KasapH.S.Feldene in the symptomatic treatment of primary dysmenorrhea. Practitioner1982; 226: 1338–41.
32.
BudoffP.W.Zomepirac sodium in the treatment of primary dysmenorrhea syndrome. N Engl J Med1982; 307: 714–9.
33.
BudoffP.W.Use of mefenamic acid in the treatment of primary dysmenorrhea. JAMA1979; 241: 2713–6.
34.
FurnissL.D.Nonsteroidal anti-inflammatory agents in the treatment of primary dysmenorrhea. Clin Pharm1982; 1: 327–33.
35.
IngemansonC., CorringtonB., SikstromB.Diclofenac in the treatment of primary dysmenorrhea. Curr Ther Res Clin Exp1981; 30: 632–9.
36.
HalbertD.R., DemersL.M.A clinical trial of indomethacin and ibuprofen in dysmenorrhea. J Reprod Med1978; 21: 219–22.
37.
ElderM.G., KapadaL.Indomethacin in the treatment of primary dysmenorrhea. Br J Obstet Gynecol1979; 86: 645–7.
38.
CorsonS.L., BologneseR.J.Ibuprofen therapy for dysmenorrhea. J Reprod Med1978; 20: 246–52.
39.
KajanojaP., VesantoT.Naproxen and indomethacin in the treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand1979; 87(suppl): 87–9.
40.
DaWoodM.Y.Dysmenorrhea and prostaglandins pharmacological and therapeutic considerations. Drugs1981; 22: 42–56.
41.
PowellJ.R., SmithR.P.Mefenamic acid (Ponstel) for treating primary spasmodic dysmenorrhea. Curr Ther Res Clin Exp1981; 29: 544–50.
42.
RosenwaksZ., Seegar-JonesG., HenslM., DubinN., GhodganokR., HoffmanS.Naproxen sodium, aspirin and placebo in primary dysmenorrhea. Am J Obstet Gynecol1981; 140: 592–8.
43.
JanbaT., LokkenP., NesheimB.Effect of acetyl-salicylic acid, paracetamol and placebo on pain and blood loss in dysmenorrheic women. Acta Obstet Gynecol Scand1979; 87(suppl): 81–5.
44.
SegreE.J.Naproxen sodium (naproxen) pharmacology, pharmacokinetics and drug interactions. J Reprod Med1980; 25: 222–5.
45.
SandahlB., UlmsterU., AndersonK.E.Trial of calcium antagonist nifedipine in the treatment of primary dysmenorrhea. Arch Gynecol1979; 227: 147–51.
